RigiTech closes an undisclosed seed round to accelerate their drone delivery network deployments and obtained first drone flight authorizations in Europe

15.09.2022

End of last spring, RigiTech closed its seed round. CEO Adam Klaptocz is not disclosing the amount raised to help accelerate the startup delivery network deployments and prepare for a Series A next year. End of August, in a breakthrough for logistics and healthcare innovation, RigiTech and France’s largest laboratory group Biogroup, obtained flight authorizations to begin regular Beyond-Visual-Line-of-Sight (BVLOS) flights between Biogroup’s laboratories in Bourgoin-Jallieu and Tignieu-Jameyzieu.

Biogroup-RigiTech-France.jpg
Representing a major milestone for both partners, this route is the first approved recurrent drone delivery route to take place within controlled airspace in France, and one of the first in Europe. “Drone regulations in Europe are constantly evolving to increase flexibility for drone operations. But because of its novelty and differences from traditional aviation, the industry has yet much to learn. I’m very proud to have participated in this process. These authorizations are helping the whole industry to push the limits of what can be done, without compromising on safety,” says Alejandro Del Estal, Head of Operations at RigiTech.

A display of incredibly successful inter-agency collaboration, this project is possible thanks to the participation and continuous communication with the Direction Générale de L’Aviation Civile (DGAC), Direction des Services de la Navigation Aérienne (DSNA), the local teams, and control towers at Lyon-Saint Exupéry Airport, the Heliport of the Centre Hospitalier Pierre Oudot (Bourgoin-Jallieu), and Frontonas airbase, Clearance, as well as indispensable feedback from the Prefecture of Isère and support from the local Bourgoin-Jallieu and Tignieu-Jameyzieu municipalities.

This first route will connect laboratories located 17.6 km apart in only 15 minutes. An immediate benefit for patients at Biogroup facilities will be the reduction in delivery time by 50%, as this route usually takes 30 minutes by car. This way, biological samples can be transported from local clinics around the area directly to the central laboratory for processing and analysis, enabling a faster diagnosis and faster access to the proper treatment. 

RigiTech’s Eiger drone is designed specifically to ensure cold-chain transportation of blood and biological samples and other medical products, including vaccines and medicine. Its large payload bay allows for efficient, long-distance flights, making the most of this sustainable delivery solution. 

As Biogroup joins the RigiTech board of directors, the newly released authorizations represent a significant first step in RigiTech’s goal to develop Europe’s largest inter-laboratory drone delivery network, encompassing multiple routes that will connect some of the over 900 Biogroup clinics and laboratories in France, Spain and throughout Europe. 

Finally, beginning of September, RigiTech announced its participation as the newest member of Drone Logistics Ecosystem (DLE). RigiTech joins DLE to collaborate with its existing partners to standardize the drone logistic industry, with regards to technical, operation, and commercialization aspects.

RigiTech won Venture Kick stage 2 in 2019 and participated in ESA BIC Switzerland
Source: RigiTech Press Release and startupticker.ch

Additional Links